Campbell & CO Investment Adviser LLC Harmony Biosciences Holdings, Inc. Transaction History
Campbell & CO Investment Adviser LLC
- $1.24 Billion
- Q4 2024
A detailed history of Campbell & CO Investment Adviser LLC transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Campbell & CO Investment Adviser LLC holds 20,351 shares of HRMY stock, worth $762,144. This represents 0.06% of its overall portfolio holdings.
Number of Shares
20,351
Previous 39,096
47.95%
Holding current value
$762,144
Previous $1.56 Million
55.16%
% of portfolio
0.06%
Previous 0.12%
Shares
6 transactions
Others Institutions Holding HRMY
# of Institutions
249Shares Held
46MCall Options Held
108KPut Options Held
49.2K-
Valor Management LLC Chicago, IL11.2MShares$420 Million100.0% of portfolio
-
Black Rock Inc. New York, NY5.84MShares$219 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.47MShares$130 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA2.61MShares$97.6 Million15.24% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.28MShares$85.4 Million0.19% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $2.22B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...